Can immediate-release oxycodone be crushed and administered via a nasogastric tube?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Immediate-Release Oxycodone Be Crushed and Administered via Nasogastric Tube?

Yes, immediate-release oxycodone tablets can be crushed and administered via a nasogastric (NG) tube, following proper medication administration protocols for enteral feeding tubes.

Key Administration Protocol

When administering crushed immediate-release oxycodone through an NG tube, you must follow these essential steps 1:

  • Flush the tube with 30 mL of water before administration
  • Administer the crushed medication individually (never mix with other medications)
  • Flush with 30 mL of water after administration
  • Use appropriate ENFit-compatible syringes to prevent misconnection errors 1

Critical Distinction: Immediate-Release vs. Extended-Release

This recommendation applies ONLY to immediate-release oxycodone formulations. The evidence is unequivocal that controlled-release or modified-release opioid formulations should never be crushed 2, 3. The 1996 European Association for Palliative Care guidelines explicitly state: "Controlled release morphine tablets should not be crushed" 2.

However, immediate-release oxycodone is specifically designed for situations where patients cannot swallow, as noted in multiple guidelines addressing alternative routes when oral administration is not feasible 4, 5.

Pharmacokinetic Considerations

The FDA label for immediate-release oxycodone indicates high oral bioavailability (60-87%) 6, and the drug reaches the systemic circulation effectively when administered enterally. Research demonstrates that:

  • Crushing immediate-release formulations does not fundamentally alter absorption when properly administered 7, 8
  • The site of delivery matters—gastric administration (via NG tube) maintains drug efficacy 1
  • Bioavailability may be decreased in the immediate postoperative period (up to 3 hours post-surgery), which should be considered when dosing 9

Important Caveats and Pitfalls

Avoid These Common Errors:

  1. Never crush extended-release or controlled-release oxycodone formulations for NG administration—this can result in potentially fatal overdose from immediate release of the entire dose 2, 3

  2. Do not mix crushed oxycodone with enteral feeding formula before administration, as drug-formula interactions can reduce efficacy 1

  3. Ensure adequate flushing (30 mL water) to prevent tube occlusion and ensure complete dose delivery 1

  4. Consider timing with enteral feeds—while specific interactions between oxycodone and enteral formula are not well-documented, the general principle is to administer medications separately from continuous feeds when possible 1

Special Patient Populations:

  • Renal impairment (eGFR <30 mL/min): Guidelines recommend using oxycodone instead of morphine in this population 4, 10, making it an appropriate choice for NG administration in renally impaired patients

  • Postoperative patients: Be aware that bioavailability via NG tube may be reduced in the immediate postoperative period (first 3 hours), potentially requiring dose adjustment 9

Clinical Context

This approach is supported by palliative care guidelines that recognize the need for alternative opioid administration routes when patients cannot swallow 4, 5. The ESPEN 2022 guidelines on home enteral nutrition specifically address drug administration through feeding tubes, emphasizing the importance of proper technique to maintain drug efficacy and tube patency 1.

The oral route should be resumed as soon as the patient can safely swallow 3, as this remains the preferred route for opioid administration when feasible.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.